Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory Drugs

Xie, 1991, Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing, Proc Natl Acad Sci, 88, 2692, 10.1073/pnas.88.7.2692 Kujubu, 1991, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue, J Biol Chem, 266, 12866, 10.1016/S0021-9258(18)98774-0 Picot, 1994, The x-ray crystal structure of the membrane protein prostaglandin H2 synthase-1, Nature, 367, 243, 10.1038/367243a0 DeWitt, 1993, Prostaglandin H synthase isoenzyme selectivity, Am J Med, 95, 40S, 10.1016/0002-9343(93)90396-7 Meade, 1993, Expression of the murine prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes in COX-1 cells, J Lipid Mediators, 6, 119 Williams, 1996, Prostaglandin endoperoxide synthase, Am J Physiol, 270, G393 Morita, 1995, Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2, J Biol Chem, 270, 10902, 10.1074/jbc.270.18.10902 Morham, 1995, Prostaglandin synthase-2 gene disruption causes severe renal pathology in the mouse, Cell, 83, 473, 10.1016/0092-8674(95)90125-6 Hempel, 1994, Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes, J Clin Invest, 93, 391, 10.1172/JCI116971 Kargman, 1996, Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts, Gastroenterology, 111, 445, 10.1053/gast.1996.v111.pm8690211 Ristimaki, 1997, Expression of cyclooxygenase-2 in human gastric carcinoma, Cancer Res, 57, 1276 Chan, 1995, Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337, J Pharmacol Exp Ther, 274, 1531 Langenbach, 1995, Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration, Cell, 83, 483, 10.1016/0092-8674(95)90126-4 Meade, 1993, Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs, J Biol Chem, 268, 6610, 10.1016/S0021-9258(18)53294-4 Glaser, 1995, Etodolac selectively inhibits human prostaglandin G/H synthase 2 (prostaglandin HS-2) versus human prostaglandin HS-1, Eur J Pharm, 281, 107, 10.1016/0014-2999(95)00302-2 Mitchell, 1994, Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase, Proc Natl Acad Sci, 90, 11693, 10.1073/pnas.90.24.11693 Laneuville, 1994, Differential inhibition of human prostaglandin endoperoxide H synthase-1 and -2 by nonsteroidal anti-inflammatory drugs, J Pharmacol Exp Ther, 271, 927 Patrignani, 1994, Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases, J Pharmacol Exp Ther, 271, 1705 Brideau, 1996, A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors, Inflamm Res, 45, 68, 10.1007/BF02265118 Lee, 1992, Nonessential role of leukotrienes as mediators of acute gastric mucosal injury induced by aspirin in rats, Dig Dis Sci, 37, 1282, 10.1007/BF01296573 Redfern, 1987, Effect of indomethacin on gastric mucosal prostaglandins in humans. Correlation with mucosal damage, Gastroenterology, 92, 969, 10.1016/0016-5085(87)90972-3 Colton T. Statistics in Medicine. Boston, Mass: Little, Brown and Co.; 1974. Piper, 1991, Corticosteroid use and peptic ulcer disease, Ann Intern Med, 114, 735, 10.7326/0003-4819-114-9-735 Physicians’ Desk Reference. 51st ed. Montvale, NJ: Medical Economics Co. 1997. Insel, 1990, Analgesic-antipyretics and antiinflammatory agents, 638 Crook, 1982, The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease, Eur J Clin Pharmacol, 21, 331, 10.1007/BF00637622 Small, 1990, Influence of H2 receptor antagonists on the disposition of flurbiprofen enantiomers, J Clin Pharmacol, 30, 660, 10.1002/j.1552-4604.1990.tb01870.x Davies, 1971, Ibuprofen, Drugs, 2, 416, 10.2165/00003495-197102050-00002 Hundal, 1991, Naproxen free plasma concentrations and unbound fractions in patients with osteoarthritis, Therapeut Drug Monitor, 13, 478, 10.1097/00007691-199111000-00002 Olive, 1993, Effect of age and disease on the pharmacokinetics of nimesulide, Drugs, 46, 73, 10.2165/00003495-199300461-00014 Duggan, 1977, The disposition of sulindac, Clin Pharmacol Ther, 21, 326, 10.1002/cpt1977213326 Friedel, 1988, Nabumetone, Drugs, 35, 504, 10.2165/00003495-198835050-00002 McMahon, 1987, Nabumetone kinetics in the young and elderly, Am J Med, 83, 92, 10.1016/0002-9343(87)90603-6 DeWitt, 1990, The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases, J Biol Chem, 265, 5192, 10.1016/S0021-9258(19)34105-5 Shimokawa, 1992, Prostaglandin endoperoxide synthase. The aspirin acetylation regastrointestinalon, J Biol Chem, 267, 12387, 10.1016/S0021-9258(19)49852-9 Lecomte, 1994, Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin, J Biol Chem, 269, 13207, 10.1016/S0021-9258(17)36820-5 Cryer, 1990, Comparison of salsalate and aspirin on mucosal injury and gastroduodenal mucosal prostaglandins, Gastroenterology, 99, 1616, 10.1016/0016-5085(90)90465-D Graham, 1985, Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa, Clin Pharmacol Ther, 38, 65, 10.1038/clpt.1985.136 Henry, 1996, Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs, BMJ, 312, 1563, 10.1136/bmj.312.7046.1563 Willkens, 1990, An overview of the long-term safety experience of nabumetone, Drugs, 40, 34, 10.2165/00003495-199000405-00008 Lanza, 1997, Selective inhibition of cyclooxygenase-2 (COX-2) with MK-0966 (250 mg q.d.) is associated with less gastroduodenal damage than aspirin (ASA) 650 mg q.i.d. or ibuprofen (IBU) 800 mg t.i.d, Gastroenterology, 112, A194 Lanza, 1997, A pilot endoscopic study of the gastroduodenal effects of SC-5835, a novel COX-2-selective inhibitor, Gastroenterology, 112, A194